Cargando…

The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions

OBJECTIVES: To evaluate the safety and efficacy of excimer laser coronary atherectomy (ELCA) in patients with in-stent restenosis chronic total occlusions (ISR CTOs). BACKGROUND: ISR CTOs are a challenge in percutaneous coronary intervention (PCI). Although they can be treated by ELCA, limited data...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Hui, Ai, Hu, Li, Le, Zheng, Naixin, Tang, Guodong, Yang, Guojian, Zhao, Ying, Sun, Fucheng, Zhang, Huiping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371826/
https://www.ncbi.nlm.nih.gov/pubmed/34407770
http://dx.doi.org/10.1186/s12872-021-02208-x
_version_ 1783739719650115584
author Li, Hui
Ai, Hu
Li, Le
Zheng, Naixin
Tang, Guodong
Yang, Guojian
Zhao, Ying
Sun, Fucheng
Zhang, Huiping
author_facet Li, Hui
Ai, Hu
Li, Le
Zheng, Naixin
Tang, Guodong
Yang, Guojian
Zhao, Ying
Sun, Fucheng
Zhang, Huiping
author_sort Li, Hui
collection PubMed
description OBJECTIVES: To evaluate the safety and efficacy of excimer laser coronary atherectomy (ELCA) in patients with in-stent restenosis chronic total occlusions (ISR CTOs). BACKGROUND: ISR CTOs are a challenge in percutaneous coronary intervention (PCI). Although they can be treated by ELCA, limited data are available on the effects of ELCA treatment in these patients. METHODS: Fifty-nine consecutive patients underwent PCI for ISR CTOs at Beijing Hospital between December 2017 and September 2020. According to whether or not ELCA was performed, they were divided into two groups. Quantitative coronary angiography (QCA) analyses were performed routinely, including measurement of the minimal lumen diameter and calculation of the percentage diameter stenosis. The procedural success rate, the frequency of peri-procedural complications, and the incidence rates of major adverse cardiac events (MACEs) over nine months were assessed. The primary endpoint in the study was the percentage diameter stenosis. RESULTS: Procedure success was achieved in most patients in both groups (75.9%). Patients in the ELCA group exhibited a lower percentage diameter stenosis (24.5 ± 9.09 vs. 35.1 ± 18.6, p = 0.048) and a larger minimal lumen diameter (2.36 ± 0.29 mm vs. 1.78 ± 0.64 mm, p < 0.001) than those in the control group and the 9-month incidence rates of MACEs did not differ (9.5% vs 15.8%, p = 0.699). CONCLUSIONS: This study demonstrated that ELCA may be a safe and effective technique in the treatment of ISR CTOs, and the use of ELCA can achieve good immediate angiographic results, as measured by QCA, without increasing peri-procedural complications or the incidence rates of 9-month MACEs.
format Online
Article
Text
id pubmed-8371826
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-83718262021-08-18 The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions Li, Hui Ai, Hu Li, Le Zheng, Naixin Tang, Guodong Yang, Guojian Zhao, Ying Sun, Fucheng Zhang, Huiping BMC Cardiovasc Disord Research OBJECTIVES: To evaluate the safety and efficacy of excimer laser coronary atherectomy (ELCA) in patients with in-stent restenosis chronic total occlusions (ISR CTOs). BACKGROUND: ISR CTOs are a challenge in percutaneous coronary intervention (PCI). Although they can be treated by ELCA, limited data are available on the effects of ELCA treatment in these patients. METHODS: Fifty-nine consecutive patients underwent PCI for ISR CTOs at Beijing Hospital between December 2017 and September 2020. According to whether or not ELCA was performed, they were divided into two groups. Quantitative coronary angiography (QCA) analyses were performed routinely, including measurement of the minimal lumen diameter and calculation of the percentage diameter stenosis. The procedural success rate, the frequency of peri-procedural complications, and the incidence rates of major adverse cardiac events (MACEs) over nine months were assessed. The primary endpoint in the study was the percentage diameter stenosis. RESULTS: Procedure success was achieved in most patients in both groups (75.9%). Patients in the ELCA group exhibited a lower percentage diameter stenosis (24.5 ± 9.09 vs. 35.1 ± 18.6, p = 0.048) and a larger minimal lumen diameter (2.36 ± 0.29 mm vs. 1.78 ± 0.64 mm, p < 0.001) than those in the control group and the 9-month incidence rates of MACEs did not differ (9.5% vs 15.8%, p = 0.699). CONCLUSIONS: This study demonstrated that ELCA may be a safe and effective technique in the treatment of ISR CTOs, and the use of ELCA can achieve good immediate angiographic results, as measured by QCA, without increasing peri-procedural complications or the incidence rates of 9-month MACEs. BioMed Central 2021-08-18 /pmc/articles/PMC8371826/ /pubmed/34407770 http://dx.doi.org/10.1186/s12872-021-02208-x Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Li, Hui
Ai, Hu
Li, Le
Zheng, Naixin
Tang, Guodong
Yang, Guojian
Zhao, Ying
Sun, Fucheng
Zhang, Huiping
The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions
title The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions
title_full The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions
title_fullStr The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions
title_full_unstemmed The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions
title_short The therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions
title_sort therapeutic effects of excimer laser coronary atherectomy therapy for in-stent restenosis chronic total occlusions
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8371826/
https://www.ncbi.nlm.nih.gov/pubmed/34407770
http://dx.doi.org/10.1186/s12872-021-02208-x
work_keys_str_mv AT lihui thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT aihu thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT lile thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT zhengnaixin thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT tangguodong thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT yangguojian thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT zhaoying thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT sunfucheng thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT zhanghuiping thetherapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT lihui therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT aihu therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT lile therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT zhengnaixin therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT tangguodong therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT yangguojian therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT zhaoying therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT sunfucheng therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions
AT zhanghuiping therapeuticeffectsofexcimerlasercoronaryatherectomytherapyforinstentrestenosischronictotalocclusions